Rheumatic Diseases: Evaluation of Health LIteracy, Medication adhereNce and Knowledges
NCT ID: NCT04187794
Last Updated: 2021-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2020-06-09
2021-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RhEumatoid Arthritis MEDIcation Adherence
NCT05413759
Impact of Literacy Level on Patient Education and Health Among People With Arthritis
NCT00023205
Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients
NCT03754855
Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
NCT05696340
Explore the Associations of Behavioral Factors With Treatment Adherence in Axial Spondyloarthritis Patients Treated With Biotherapy.
NCT04925037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interview patient
to investigate an association between literacy level and medication adherence in patients with rheumatic diseases.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having at least 6 months of disease-modifying rheumatic treatment (methotrexate and/or targeted treatment (anti-JAK) and/or subcutaneous biotherapies)
* Understanding French,
* With good visual acuity.
Exclusion Criteria
* Pregnant, parturient and lactating women
* Persons deprived of their liberty
* Major persons who are subject to a legal protection measure (guardianship, curators)
* Persons not affiliated to a social security system
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Laure YAILIAN, PD
Role: PRINCIPAL_INVESTIGATOR
Service hospitalier de rhumatologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de rhumatologie Hôpital Edouard Herriot
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL19_0746
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.